Introduction The prevalence of obesity in Chinese adults increased from 1991 to 2000; however, recent changes in this trend are unclear. This study aims to estimate the current prevalence of obesity and to assess trends in obesity and BMI distribution in Chinese adults from 1991 through 2011. Methods Height and weight measurements of 12,249 Chinese adults from the 2011 China Health and Nutrition Survey were analyzed (in 2013) together with China Health and Nutrition Survey data for 1991–2009. Obesity was defined as BMI ≥28.0 based on the Working Group on Obesity in China criteria. Results In the 2011 survey, the age-adjusted mean BMI was 23.8 (95% CI=23.7, 23.9) for men and 23.4 (95% CI=23.2, 23.5) for women. The age-adjusted prevalence of obesity was 11.3% (95% CI=10.8%, 11.9%) overall, 11.8% (95% CI=10.8%, 12.6%) among men, and 11.0% (95% CI=10.3%, 11.8%) among women. Estimates of age-adjusted obesity prevalence among the Chinese population were significantly lower than those of the U.S. population (all p<0.05). Over the 20-year period, the prevalence of obesity increased from 2.88% to 11.8% among men (age-adjusted annual change in OR=1.08, 95% CI=1.07, 1.09, p<0.001) and from 4.55% to 11.0% among women (OR=1.05, 95% CI=1.05, 1.06, p<0.001). Similar significant findings were observed for both men and women based on WHO recommendations. Conclusions The prevalence of obesity among both Chinese men and women increased significantly from 1991 through 2011, particularly among men.
BackgroundThe prevalence of abdominal obesity is increasing dramatically worldwide. This study aimed to estimate the current prevalence of abdominal obesity from the 2011 China Health and Nutrition Survey (CHNS) and compare the data with other countries.MethodsWaist circumference (WC) of 12,326 Chinese adults (aged 20 years or older) from the 2011 CHNS were analyzed by age group and region. Abdominal obesity was defined as a WC ≥90 cm for men and WC ≥80 cm for women based on World Health Organization (WHO) recommendations for Asians.ResultsIn 2011, the age-adjusted mean WC was 85.9 cm (95% confidence interval [CI], 85.6–86.2 cm) for men and 80.7 cm (95% CI, 80.4–80.9 cm) for women. Based on the WHO recommendations, the age-adjusted prevalence of abdominal obesity was 44.0% (95% CI, 43.1%–44.8%) overall, 35.3% (95% CI, 34.1%–36.6%) in men, and 51.7% (95% CI, 50.5%–52.9%) in women. Moreover, the age-adjusted prevalence was 44.0% (95% CI, 42.7%–45.2%) in rural populations, 42.5% (95% CI, 40.7%–44.2%) in urban populations, and 45.2% (95% CI, 43.5%–46.9%) in megacity populations. The prevalence in China (35.3% for men and 51.7% for women) was lower than in Japan (50.8% for men) and the United States (43.5% for men and 64.7% for women). Similar results were observed when applying the criteria suggested by the Working Group on Obesity in China.ConclusionsIn 2011, the age-adjusted prevalence of abdominal obesity in China was 35.3% in men and 51.7% in women.
It has been reported that single nucleotide polymorphisms (SNPs) of Alpha-synuclein (SNCA) are associated with Parkinson's disease (PD). Some researchers have attempted to validate this finding in various ethnic populations. The results of studies concerning SNCA polymorphisms and PD susceptibility remain conflicting. To evaluate the association between these SNPs and PD, the authors conducted a series of meta-analyses using a predefined protocol. Databases including PubMed, MEDLINE and PD gene were searched to identify relevant studies. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to assess the strength of the association. All analyses were calculated using STATA11.0. A total of 19 studies on the SNPS rs181489, rs356186, rs356219, rs894278, rs2583988, rs2619363, rs2619364, rs2737029, rs10005233 and rs11931074 were included. This meta-analysis showed that eight out of these 10 candidate SNPs may be associated with PD risk. Significant association was found between PD and the following SNPs: rs181489, rs356186, rs356219, rs894278 rs2583988, rs2619364, rs10005233 and rs11931074. Among these SNPs, rs356186 was found to be the only SNP that may play a protective role in Parkinson's disease. These results suggest that the SNCA gene may be associated with PD.
Both the prevalence of hypertension and the percentage of current use of antihypertensive medication significantly increased from 1991 to 2011. Currently, about one-fifth of Chinese adults are hypertensive; however, only 17.5% of hypertension is controlled.
SUMMARYDo men who carry mutations in USP26 have an increased risk of infertility? The association between mutations in USP26 gene and male infertility has been studied intensively. However, the results from different groups are controversial. In particular, biological function of the mutant proteins remains to be elucidated. In this study, we conducted a USP cleavage assay and a meta-analysis of the published literature (up to 31 May 2013) to evaluate the impact of five frequent mutations (NM_031907.1: c.363_364insACA, c.494T>C, c.1423C>T, c.1090C>T, c.1737G>A) on enzymatic activity of the USP26 and to assess the strength of the association between those mutations and male infertility. The USP cleavage assay showed that those mutations do not affect USP26 enzymatic activity. Moreover, the results of meta-analysis of ten case-control studies (in total 1716 patients and 2597 controls) revealed no significant association (P > 0.05) between USP26 mutations and male infertility. The pooled ORs were 1.58 (95% CI: 0.81, 3.10) for cluster mutations (c.363_364insACA, c.494T>C, c.1423C>T), 1.60 (95% CI: 0.93, 2.74) for c.1090 C>T and 2.64 (95% CI: 0.97, 7.20) for c.1737 G>A. Evidence from both enzymatic and meta-analyses does not support a direct association between USP26 variants and male infertility. Further research is necessary to study the biological function of USP26, which may provide clues as to the regulation of androgen receptor signalling.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.